D-0942-2017 Class III Terminated
FDA drug recall D-0942-2017 was initiated by Lantheus MI Radipharmaceuticals Inc. on May 18, 2017 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications; out of specification result for Acetonitrile residual solvent The recall status is terminated (terminated Dec 6, 2017). Affected quantity: 26 doses.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 12, 2017
- Initiation Date
- May 18, 2017
- Termination Date
- Dec 6, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 26 doses
Product description
Fludeoxyglucose F 18 Injection, 20mCi/mL to 200 mCi/mL at EOS, 30 mL Multiple-Dose Vial, Rx Only, Manufactured by: Lantheus MI Radiopharmaceuticals, Inc., San Juan, PR --- NDC 11994-015-01
Reason for recall
Failed Impurities/Degradation Specifications; out of specification result for Acetonitrile residual solvent
Distribution pattern
Puerto Rico
Code information
Lot: FDG170518-01, exp 5/18/2017
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0942-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026